Literature DB >> 8956320

Incidence of corneal ulceration in Madurai district, South India.

C A Gonzales1, M Srinivasan, J P Whitcher, G Smolin.   

Abstract

OBJECTIVE: To determine the incidence of corneal ulceration in Madurai District, South India.
DESIGN: Retrospective incidence study.
SETTING: General community. PATIENTS: All patients who reside in Madurai District and presented to an ophthalmologist in 1993 with corneal ulceration. MAIN OUTCOME MEASURE: Cases of corneal ulceration.
RESULTS: 1148 cases of corneal ulceration were recorded in the medical records of those ophthalmologists who maintained records. Based upon the recorded number of cases, the annual incidence per 10,000 population was 3.4. The ratio of male to female patients was 1.6:1.0. When the estimated number of cases from those without records was added to the total number of recorded cases the annual incidence was 11.3 per 10,000 population.
CONCLUSION: Corneal ulceration is a common occurrence in South India. While the true incidence of this problem is impossible to determine because of the lack of medical records, we believe our estimation of the incidence to be close to the true incidence in this community.

Entities:  

Mesh:

Year:  1996        PMID: 8956320     DOI: 10.3109/09286589609080122

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  57 in total

1.  Initial therapy for suppurative microbial keratitis in Iraq.

Authors:  Faiz Al-Shakarchi
Journal:  Br J Ophthalmol       Date:  2007-06-27       Impact factor: 4.638

2.  Topical Corticosteroids in the Management of Bacterial Keratitis.

Authors:  Sonal S Tuli
Journal:  Curr Ophthalmol Rep       Date:  2013-12

Review 3.  The persistent dilemma of microbial keratitis: Global burden, diagnosis, and antimicrobial resistance.

Authors:  Lawson Ung; Paulo J M Bispo; Swapna S Shanbhag; Michael S Gilmore; James Chodosh
Journal:  Surv Ophthalmol       Date:  2018-12-24       Impact factor: 6.048

4.  The steroids for corneal ulcers trial: study design and baseline characteristics.

Authors:  Muthiah Srinivasan; Jeena Mascarenhas; Revathi Rajaraman; Meenakshi Ravindran; Prajna Lalitha; David V Glidden; Kathryn J Ray; Kevin C Hong; Catherine E Oldenburg; Salena M Lee; Michael E Zegans; Stephen D McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  Arch Ophthalmol       Date:  2011-10-10

5.  Corneal ulceration in south-east Asia III: prevention of fungal keratitis at the village level in south India using topical antibiotics.

Authors:  M Srinivasan; M P Upadhyay; B Priyadarsini; R Mahalakshmi; J P Whitcher
Journal:  Br J Ophthalmol       Date:  2006-08-17       Impact factor: 4.638

6.  Microbial keratitis at a referral center in Brazil.

Authors:  Angelino Julio Cariello; Renato Magalhães Passos; Maria Cecilia Zorat Yu; Ana Luisa Hofling-Lima
Journal:  Int Ophthalmol       Date:  2011-03-30       Impact factor: 2.031

7.  Does in vitro susceptibility predict clinical outcome in bacterial keratitis?

Authors:  Aiyin Chen; Lalitha Prajna; Muthiah Srinivasan; Rajendran Mahalakshmi; John P Whitcher; Stephen McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2008-01-22       Impact factor: 5.258

8.  Trends in antibiotic resistance in bacterial keratitis isolates from South India.

Authors:  Prajna Lalitha; Geetha Manoharan; Rajaram Karpagam; Namperumalsamy V Prajna; Muthiah Srinivasan; Jeena Mascarenhas; Manoranjan Das; Travis C Porco; Thomas M Lietman; Vicky Cevallos; Jeremy D Keenan
Journal:  Br J Ophthalmol       Date:  2016-04-29       Impact factor: 4.638

9.  A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis.

Authors:  N V Prajna; R K John; P K Nirmalan; P Lalitha; M Srinivasan
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

10.  Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade.

Authors:  Usha Gopinathan; Savitri Sharma; Prashant Garg; Gullapalli N Rao
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.